Endothelial FSHR was detected by immunohistochemical and immunoblotting analysis in samples obtained from >1,000 patients with breast, prostate, colon, pancreas, urinary bladder, kidney, lung, liver, stomach, testis, and ovarian cancer (7). The gene discussed is FSHR; the disease is ovarian cancer.